Skip to content

Drug interactions

Eliglustat + Verapamil

Severity: Major

Eliglustat and Verapamil: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Verapamil is a moderate CYP3A4 inhibitor, and eliglustat is metabolized by CYP2D6 and CYP3A4. Eliglustat levels can rise, increasing the risk of PR, QRS and QT prolongation, and verapamil also affects cardiac conduction.

What this interaction means in plain words

Eliglustat and Verapamil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Eliglustat belongs to Miscellaneous; Verapamil belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Verapamil inhibits CYP3A4, reducing eliglustat clearance, with additive conduction effects.

What to do

Avoid in CYP2D6 intermediate or poor metabolizers. In extensive metabolizers, reduce eliglustat to 84 mg once daily and monitor ECG.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eliglustat and Verapamil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Eliglustat with Verapamil?

MediHelp rates the interaction as major. Eliglustat and Verapamil can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Verapamil is a moderate CYP3A4 inhibitor, and eliglustat is metabolized by CYP2D6 and CYP3A4. Eliglustat levels can rise, increasing the risk of PR, QRS and QT prolongation, and verapamil also affects cardiac conduction.

How serious is the interaction between Eliglustat and Verapamil?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid in CYP2D6 intermediate or poor metabolizers. In extensive metabolizers, reduce eliglustat to 84 mg once daily and monitor ECG.

What other medicines interact with Verapamil?

MediHelp also lists interactions of Verapamil with, for example, Dofetilide, Flibanserin, Lomitapide. The full list is on the Verapamil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in